# Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Forehead and Frown Lines

> **NCT01391299** · NA · COMPLETED · sponsor: **Allergan** · enrollment: 175 (actual)

## Conditions studied

- Facial Rhytides
- Glabellar Frown Lines

## Interventions

- **BIOLOGICAL:** botulinum toxin Type A
- **DRUG:** Normal Saline

## Key facts

- **NCT ID:** NCT01391299
- **Lead sponsor:** Allergan
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-06-01
- **Primary completion:** 2011-10-18
- **Final completion:** 2012-02-28
- **Target enrollment:** 175 (ACTUAL)
- **Last updated:** 2019-04-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01391299

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01391299, "Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Forehead and Frown Lines". Retrieved via AI Analytics 2026-09-26 from https://api.ai-analytics.org/clinical/NCT01391299. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*